Choosing the right animal model for infectious disease research

Animal Models and Experimental Medicine

Volumn 1, Issue 2, 2018, Pages 100-108

  Swearengen, James R ^a  

^a AAALAC International   (United States)

Author keywords

animal; disease; extrinsic; fidelity; infectious; intrinsic; matrix; model; research; validity

Indexed keywords

EID: 85064465559     PISSN: 20965451     EISSN: 25762095     Source Type: Journal    
DOI: 10.1002/ame2.12020     Document Type: Review

References (35)

1. Institute for Laboratory Animal Research (U.S.). Committee on New and Emerging Models in Biomedical and Behavioral Research. Biomedical Models and Resources: Current Needs and Future Opportunities. Washington, DC: National Academy Press; 1998.
2. Kriesberg N. Animals as Models. https://ori.hhs.gov/education/products/ncstate/models.htm. Accessed January 16, 2018.
3. Quimby F. Animal models in biomedical research. In: Fox JG, Anderson LC, Otto G, Pritchett-Corning KR, Whary M, eds. Laboratory Animal Medicine. New York, NY: Academic Press; 2002:1185-1225.
4. National Research Council (U.S.). Committee on Models for Biomedical Research. Models for Biomedical Research: A New Perspective. Washington, DC: National Academy Press; 1985:12-23.
5. Hau J. Animal models for human disease. In: Conn MP, ed. Sourcebook of Models for Biomedical Research. Totowa, NJ: Humana Press; 2008:3-8.
6. Institute for Laboratory Animal Research (U.S.). Committee on Animal Models for Assessing Countermeasures to Bioterrorism Agents. Animal Models for Assessing Countermeasures to Bioterrorism Agents. Washington, DC: National Academy Press; 2011:68.
7. Needham AJ, Kibart M, Crossley H, Ingham PW, Foster SJ. Drosophila melanogaster as a model host for Staphylococcus aureus infection. Microbiology. 2004;150:2347-2355.
8. Garsin DA, Sifri CD, Mylonakis E, et al. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci USA. 2001;98:10892-10897.
9. Riley WJ. Insulin dependent diabetes mellitus, an autoimmune disorder? Clin Immunol Immunopathol. 1989;53:S92-S98.
10. Jun HS, Yoon JW. A new look at viruses in type 1 diabetes. ILAR J. 2004;45:349-374.
11. DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, Bavari S. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis. 2002;185:1754-1760.
12. Pruimboom-Brees IM, et al. Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci USA. 2000;97:10325-10329.
13. Tesh VL, Burns JA, Owens JW, et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun. 1993;61:3392-3402.
14. Keusch GT, Jacewicz M, Mobassaleh M, Donohue-Rolfe A. Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects. Rev Infect Dis. 1991;13:S304-S310.
15. Lyons CR, Lovchik J, Hutt J. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect Immun. 2004;72:4801-4809.
16. Chang TW, Bartlett JG, Gorbach SL, Onderdonk AB. Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun. 1978;20:526-529.
17. Hardy WD Jr, Essex M. FeLV-induced feline acquired immune deficiency syndrome. A model for human AIDS. Prog Allergy. 1986;37:353-376.
18. Tsolis RM, Kingsley RA, Townsend SM, Ficht TA, Adams LG, Bäumier AJ. Of mice, calves, and men. Comparison of the mouse typhoid model with other Salmonella infections. Adv Exp Med Biol. 1999;473:261-274.
19. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol. 2001;125:243-253.
20. Hooper LV, Gordon JI. Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology. 2001;11:1R-10R.
21. Lipman NS, Perkins SE. Factors that may influence animal research. In: Fox JG, Anderson LC, Otto G, Pritchett-Corning KR, Whary M, eds. Laboratory Animal Medicine. New York, NY: Academic Press; 2002:1143-1184.
22. Gardner MB, Luciw PA. Animal models of AIDS. FASEB J. 1989;3:2593-2606.
23. Burwinkel M, Holtkamp N, Baier M. Biology of infectious proteins: lessons from yeast prions. Lancet. 2004;364:1471-1472.
24. Leader RA, Padgett GA. The genesis and validation of animal models. Am J Pathol. 1980;101:s11-s16.
25. National Research Council (U.S.). Committee on Animal Models for Research on Aging. Mammalian Models for Research on Aging. Washington, DC: National Academy Press; 1981:1-6.
26. Palm P, McNerney J, Hatch T. Respiratory dust retention in small animals. AMA Arch Indust Health. 1956;13:355-365.
27. Dressman JB, Yamada K. Animal models for oral drug absorption. In: Welling P, Tse FL, eds. Pharmaceutical Bioequivalence. New York, NY: Dekker; 1991:235-266.
28. Stevens CE. Comparative physiology of the digestive system. In: Swenson MJ, ed. Dukes Physiology of Domestic Animals. Ithaca, NY: Comstock; 1993:216-232.
29. Ohishi I. Oral toxicities of Clostridium botulinum type A and B toxins from different strains. Infect Immun. 1984;43:487-490.
30. Sergeyeva T. Detection of botulinal toxin and type A microbe in the organism of sick animals and in the organs of cadavers. Zhurnal Mikrobiologii. 1962;33:96-102.
31. Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295:302-304.
32. Zhou D, Han Y, Song Y, et al. DNA microarray analysis of genome dynamics in Yersinia pestis: insights into bacterial genome microevolution and niche adaptation. J Bacteriol. 2004;86:5138-5146.
33. Jahrling PB, Geisbert TW, Jaax NK, Hanes MA, Ksiazek TG, Peters CJ. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Arch Virol Suppl. 1996;11:115-134.
34. Die Koch R. Die Aetiologie der Tuberkulose. Mitt Kaiserl Gesundheitsamt. 1884;2:1-88.
35. Animal Rule Summary. United States Food and Drug Administration. https://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMRegulatoryScience/ucm391665.htm. Updated November 11, 2017. Accessed January 22, 2018.